Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Target (TGT) upgraded to Overweight from Neutral at JPMorgan with analyst Christopher Horvers saying he believes the shares are undervalued and he sees potential upside to consensus estimates. 2. Philip Morris (PM) upgraded to Equal Weight from Underweight at Barclays with analyst Gaurav Jain saying unlike British American Tobacco (BTI), Philip Morris' Canadian subsidiary value is more than the value of the liability. 3. Booking Holdings (BKNG) upgraded to Buy from Neutral at Citi saying Booking's valuation, following the stock's underperformance this year, now better reflects the business slowdown it faces and is attractive on a cash flow basis. 4. Vertex (VRTX) assumed with a Buy from Neutral at Goldman Sachs with analyst Salveen Richter saying he believes the likely approval of the triple combination regimen in 2020 will extend Vertex's cystic fibrosis opportunity to ~90% of the market. 5. Ferrari (RACE) upgraded to Outperform from In Line at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

In a regulatory filing, Booking Holdings disclosed that its CEO Glenn Fogel sold 750 shares of common stock on April 15th in a total transaction size of $2.65M.